Cardiome Reaches Agreement With Merck to Retire Debt and Close Line of Credit
December 11, 2012 08:00 ET
|
Cardiome Pharma Corp
VANCOUVER, British Columbia, Dec. 11, 2012 (GLOBE NEWSWIRE) -- Cardiome Pharma Corp. (Nasdaq:CRME) (TSX:COM) today announced that the company has reached an agreement with Merck to settle its debt...
Cardiome Reports Third Quarter Results
November 13, 2012 16:25 ET
|
Cardiome Pharma Corp
VANCOUVER, British Columbia, Nov. 13, 2012 (GLOBE NEWSWIRE) -- Cardiome Pharma Corp. (Nasdaq:CRME) (TSX:COM) today reported financial results for the third quarter ended September 30, 2012. Amounts,...
NASDAQ Grants Cardiome 180 Day Extension to Regain Compliance With Bid Price Requirement
October 31, 2012 17:00 ET
|
Cardiome Pharma Corp
VANCOUVER, British Columbia, Oct. 31, 2012 (GLOBE NEWSWIRE) -- Cardiome Pharma Corp. (Nasdaq:CRME) (TSX:COM) announced today that the NASDAQ Listing Qualifications Staff has granted the company's...
NASDAQ Approves Cardiome's Request to Transfer Its Listing to The NASDAQ Capital Market
October 25, 2012 16:15 ET
|
Cardiome Pharma Corp
VANCOUVER, Canada, Oct. 25, 2012 (GLOBE NEWSWIRE) -- Cardiome Pharma Corp. (TSX:COM) (Nasdaq:CRME) announced today that the NASDAQ Listing Qualifications Staff has approved the Company's request to...
Cardiome to Hold Conference Call
September 26, 2012 08:05 ET
|
Cardiome Pharma Corp
VANCOUVER, British Columbia, Sept. 26, 2012 (GLOBE NEWSWIRE) -- Cardiome Pharma Corp. (Nasdaq:CRME) (TSX:COM) today announced that a teleconference call and webcast will be held on Wednesday,...
Merck Returns Global Marketing and Development Rights for Vernakalant to Cardiome
September 26, 2012 08:04 ET
|
Cardiome Pharma Corp
VANCOUVER, Canada and WHITEHOUSE STATION, N.J., Sept. 26, 2012 (GLOBE NEWSWIRE) -- Cardiome Pharma Corp. (Nasdaq:CRME) (TSX:COM) and Merck (NYSE:MRK), known as MSD outside the United States and...
Cardiome Announces Appointment of Jennifer Archibald as Chief Financial Officer
September 20, 2012 16:30 ET
|
Cardiome Pharma Corp
VANCOUVER, British Columbia, Sept. 20, 2012 (GLOBE NEWSWIRE) -- Cardiome Pharma Corp. (Nasdaq:CRME) (TSX:COM) is pleased to announce the appointment of Jennifer Archibald as Chief Financial Officer...
Cardiome Notes Updated Guidelines From European Society of Cardiology Now Include Brinavess(TM) (Vernakalant) for Infusion
September 10, 2012 08:45 ET
|
Cardiome Pharma Corp
VANCOUVER, B.C., Sept. 10, 2012 (GLOBE NEWSWIRE) -- Cardiome Pharma Corp. (Nasdaq:CRME) (TSX:COM) today noted that the European Society of Cardiology (ESC) has issued updated treatment guidelines for...
Cardiome to Hold Investor Update Call
August 21, 2012 16:45 ET
|
Cardiome Pharma Corp
VANCOUVER, British Columbia, Aug. 21, 2012 (GLOBE NEWSWIRE) -- Cardiome Pharma Corp. (Nasdaq:CRME) (TSX:COM) today announced that a teleconference call and webcast will be held on Wednesday, August...
Cardiome Reports Second Quarter Results
August 07, 2012 20:30 ET
|
Cardiome Pharma Corp
VANCOUVER, British Columbia, Aug. 7, 2012 (GLOBE NEWSWIRE) -- Cardiome Pharma Corp. (Nasdaq:CRME) (TSX:COM) today reported financial results for the second quarter ended June 30, 2012. Amounts, unless...